PEOPLE - Synthetic Blood International in the US makes appointment:
This article was originally published in Clinica
David John has joined Synthetic Blood International in the US as chief financial officer. Mr John has had over 25 years of financial and administrative experience in a range of industries. Synthetic Blood International is developing three products - an implantable glucose sensor for diabetics; Oxycyte, a blood substitute; and Fluorovent, a liquid ventilation product.